A phase 2 clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms.
Dwight H OwenBrooke BennerLai WeiVineeth K SukrithanAshima GoyalYe ZhouCarly PilcherSheryl-Ann SuffrenGwen ChristensonNancy CurtisMegan JukichEmily SchwarzHimanshu SavardekarRuthann NormanSarah FergusonBarbara KleiberRobert WesolowskiWilliam E CarsonGregory A OttersonClaire F VerschraegenManisha H ShahBhavana KondaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Combination nivolumab and temozolomide demonstrated promising activity in NEN.